Home > News > Serologicals Acquisition Helps Millipores Q4 Sales Grow 50 Percent
Industry Updates New Products Supplier News Upcoming Events business Tech Articles web

Serologicals Acquisition Helps Millipores Q4 Sales Grow 50 Percent

Hits:1889   Date: 2/5/2007
Millipore yesterday said fourth-quarter revenues increased 50 percent as R&D spending rose 41 percent and profit leapt 1,700 percent.
 
Total receipts for the three months ended Dec. 31, 2006 increased to $383 million from $256 million year over year.
 
Compared with the fourth quarter of 2005, sales in the company’s Bioprocess segment was up 42 percent to $224 million, while its Bioscience segment gained 61 percent with sales of $158 million.
 
In a statement, CEO Martin Madaus attributed much of the growth to improved execution, BioProcess and Bioscience sales and acquisitions, including the purchase in July of Serologicals for $1.4 billion.
 
R&D spending increased to $23.9 million from $17 million year over year.
 
The company said profits increased to $18.5 million from $1 million in the year-ago period.
 
Millipore said it had around $537 million in cash and cash equivalents as of Dec. 31.